Recall of Phuc Hung Panax Pseudoginseng powder due to bacterial contamination

The Drug Administration of Vietnam, Ministry of Health, has just sent an official dispatch to the Hanoi Department of Health, the Central Institute for Drug Control, the Ho Chi Minh City Institute for Drug Control and Phuc Hung Oriental Medicine Company Limited regarding the handling of Phuc Hung Panax pseudoginseng powder that does not meet quality standards.

The recalled batch of medicine has registration number VD-24513-16, batch number 041117, production date November 21, 2017, expiration date November 21, 2019.

The test results of the Central Institute for Drug Control found that the Phuc Hung Panax pseudoginseng powder sample did not meet the quality standards for bacterial contamination. Therefore, the Drug Administration has decided to suspend the circulation of the above batch of medicine in Hanoi.

Within 2 days from the date of signing the document, the manufacturing company is responsible for coordinating with the drug distributor to send a recall notice to wholesalers, retailers, and users of the above drug batch and conduct the recall in Hanoi.

Then, send the recall report to the Drug Administration of Vietnam and the Hanoi Department of Health before August 14, including the production quantity, distribution quantity, production date, and recalled quantity.

Phuc Hung Panax pseudoginseng powder product is indicated for body nourishment, enhancing resistance, stopping bleeding, removing blood stasis, reducing pain, cleansing bad blood for postpartum women, stopping bleeding in cases of nosebleeds, bloody dysentery, vomiting blood.

In addition, the drug is also used to reduce pain when damage causes blood to clot under the skin, blood accumulates into masses, limits the growth of tumors in cases of cancer, and reduces inflammation in cases of gastritis and colitis.